Kurt J Hilzinger
CIK 1191504 · View on SEC EDGAR ↗
First SEC filing: Oct. 4, 2021 · Latest: Oct. 4, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 5, 2022 | OTLK | P | 15,662 | $1.23 | $19,264 | 473,117 Direct | +3.42% | Acquired | -97.2% (price as of 2026-08-21) |
| Oct. 4, 2022 | OTLK | P | 95,541 | $1.29 | $123,248 | 457,455 Direct | +26.40% | Acquired | -97.3% (price as of 2026-08-21) |
| Oct. 3, 2022 | OTLK | P | 41,798 | $1.25 | $52,248 | 361,914 Direct | +13.06% | Acquired | -97.2% (price as of 2026-08-21) |
| Sept. 30, 2022 | OTLK | P | 33,199 | $1.26 | $41,831 | 320,116 Direct | +11.57% | Acquired | -97.2% (price as of 2026-08-21) |
| Sept. 29, 2022 | OTLK | P | 13,800 | $1.19 | $16,422 | 286,917 Direct | +5.05% | Acquired | -97.1% (price as of 2026-08-21) |
| March 1, 2022 | OTLK | P | 27,708 | $1.69 | $46,827 | 273,117 Direct | +11.29% | Acquired | -97.9% (price as of 2026-08-21) |
| Feb. 28, 2022 | OTLK | P | 6,000 | $1.60 | $9,600 | 245,409 Direct | +2.51% | Acquired | -97.8% (price as of 2026-08-21) |
| Feb. 24, 2022 | OTLK | P | 41,160 | $1.46 | $60,094 | 239,409 Direct | +20.76% | Acquired | -97.6% (price as of 2026-08-21) |
| Feb. 23, 2022 | OTLK | P | 79,535 | $1.44 | $114,530 | 198,249 Direct | +67.00% | Acquired | -97.6% (price as of 2026-08-21) |
| Feb. 22, 2022 | OTLK | P | 95,597 | $1.49 | $142,440 | 118,714 Direct | +413.54% | Acquired | -97.7% (price as of 2026-08-21) |
| Feb. 4, 2019 | OTLK | P | 5,983 | $0.80 | $4,786 | 184,947 Direct | +3.34% | Acquired | -99.5% (price as of 2026-08-21) |
| Feb. 1, 2019 | OTLK | P | 8,200 | $0.77 | $6,314 | 178,964 Direct | +4.80% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 31, 2019 | OTLK | P | 6,300 | $0.75 | $4,725 | 170,764 Direct | +3.83% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 30, 2019 | OTLK | P | 4,890 | $0.72 | $3,521 | 164,464 Direct | +3.06% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 29, 2019 | OTLK | P | 5,400 | $0.73 | $3,942 | 159,574 Direct | +3.50% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 28, 2019 | OTLK | P | 15,884 | $0.71 | $11,278 | 154,174 Direct | +11.49% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 25, 2019 | OTLK | P | 10,828 | $0.69 | $7,471 | 138,290 Direct | +8.50% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 23, 2019 | OTLK | P | 2,266 | $0.67 | $1,518 | 127,462 Direct | +1.81% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 22, 2019 | OTLK | P | 10,749 | $0.68 | $7,309 | 125,196 Direct | +9.39% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 17, 2019 | OTLK | P | 2,300 | $0.69 | $1,587 | 114,447 Direct | +2.05% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 16, 2019 | OTLK | P | 800 | $0.68 | $544 | 112,147 Direct | +0.72% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 15, 2019 | OTLK | P | 2,266 | $0.70 | $1,586 | 111,347 Direct | +2.08% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 14, 2019 | OTLK | P | 4,399 | $0.71 | $3,123 | 109,081 Direct | +4.20% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 10, 2019 | OTLK | P | 6,053 | $0.70 | $4,237 | 104,682 Direct | +6.14% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 9, 2019 | OTLK | P | 2,792 | $0.73 | $2,038 | 98,629 Direct | +2.91% | Acquired | -99.4% (price as of 2026-08-21) |
| Jan. 8, 2019 | OTLK | P | 6,410 | $0.65 | $4,166 | 95,837 Direct | +7.17% | Acquired | -99.3% (price as of 2026-08-21) |
| Jan. 7, 2019 | OTLK | P | 5,166 | $0.63 | $3,255 | 89,427 Direct | +6.13% | Acquired | -99.3% (price as of 2026-08-21) |
| Jan. 4, 2019 | OTLK | P | 6,205 | $0.59 | $3,661 | 84,261 Direct | +7.95% | Acquired | -99.3% (price as of 2026-08-21) |
| Jan. 3, 2019 | OTLK | P | 4,200 | $0.59 | $2,478 | 78,056 Direct | +5.69% | Acquired | -99.3% (price as of 2026-08-21) |
| Jan. 2, 2019 | OTLK | P | 1,640 | $0.59 | $968 | 73,856 Direct | +2.27% | Acquired | -99.3% (price as of 2026-08-21) |
| Dec. 31, 2018 | OTLK | P | 11,349 | $0.59 | $6,696 | 72,216 Direct | +18.65% | Acquired | -99.3% (price as of 2026-08-21) |
| Dec. 28, 2018 | OTLK | P | 11,910 | $0.52 | $6,193 | 60,867 Direct | +24.33% | Acquired | -99.2% (price as of 2026-08-21) |
| Dec. 27, 2018 | OTLK | P | 730 | $0.51 | $372 | 48,957 Direct | +1.51% | Acquired | -99.1% (price as of 2026-08-21) |
| Dec. 26, 2018 | OTLK | P | 5,714 | $0.54 | $3,086 | 48,227 Direct | +13.44% | Acquired | -99.2% (price as of 2026-08-21) |
| Dec. 24, 2018 | OTLK | P | 1,113 | $0.66 | $735 | 42,513 Direct | +2.69% | Acquired | -99.3% (price as of 2026-08-21) |
| Dec. 21, 2018 | OTLK | P | 3,600 | $0.65 | $2,340 | 41,400 Direct | +9.52% | Acquired | -99.3% (price as of 2026-08-21) |
Showing latest 100 of 169 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 30, 2026 | HUM | Restricted Stock Units [F3] | Humana Common (233) | — | — | 233 | Acquired |
| March 31, 2026 | HUM | Restricted Stock Units [F3] | Humana Common (536) | — | — | 536 | Acquired |
| Jan. 2, 2026 | HUM | Restricted Stock Units [F1] | Humana Common (766) | — | — | 766 | Acquired |
| Dec. 31, 2025 | HUM | Restricted Stock Units [F3] | Humana Common (357) | — | — | 357 | Acquired |
| Dec. 31, 2025 | HUM | Restricted Stock Units [F2] | Humana Common (611) | — | — | 611 | Acquired |
| Sept. 30, 2025 | HUM | Restricted Stock Units [F3] | Humana Common (364) | — | — | 364 | Acquired |
| June 30, 2025 | HUM | Restricted Stock Units [F3] | Humana Common (399) | — | — | 399 | Acquired |
| March 31, 2025 | HUM | Restricted Stock Units [F3] | Humana Common (345) | — | — | 345 | Acquired |
| Jan. 2, 2025 | HUM | Restricted Stock Units [F1] | Humana Common (783) | — | — | 783 | Acquired |
| Dec. 31, 2024 | HUM | Restricted Stock Units [F3] | Humana Common (673) | — | — | 673 | Acquired |
| Dec. 31, 2024 | HUM | Restricted Stock Units [F2] | Humana Common (565) | — | — | 565 | Acquired |
| Oct. 3, 2024 | OTLK | Stock Option (Right to Buy) | Common Stock (18,672) | $5.25 | Oct. 3, 2034 | 18,672 | Acquired |
| Oct. 1, 2024 | OTLK | Stock Option (Right to Buy) | Common Stock (56,636) | $5.22 | Oct. 1, 2034 | 56,636 | Acquired |
| Oct. 1, 2024 | OTLK | Stock Option (Right to Buy) | Common Stock (105,151) | $5.22 | Oct. 1, 2034 | 105,151 | Acquired |
| Sept. 30, 2024 | HUM | Restricted Stock Units [F3] | Humana Common (295) | — | — | 295 | Acquired |
| June 28, 2024 | HUM | Restricted Stock Units [F3] | Humana Common (246) | — | — | 246 | Acquired |
| March 28, 2024 | HUM | Restricted Stock Units [F3] | Humana Common (270) | — | — | 270 | Acquired |
| March 7, 2024 | OTLK | Stock Option (Right to Buy) | Common Stock (94,441) | $0.41 | March 7, 2034 | 94,441 | Acquired |
| Jan. 2, 2024 | HUM | Restricted Stock Units [F4] | Humana Common (430) | — | — | 430 | Acquired |
| Dec. 31, 2023 | HUM | Restricted Stock Units [F3] | Humana Common (211) | — | — | 211 | Acquired |
| Dec. 31, 2023 | HUM | Restricted Stock Units [F2] | Humana Common (304) | — | — | 304 | Acquired |
| Oct. 4, 2023 | OTLK | Stock Option (Right to Buy) | Common Stock (286,670) | $0.24 | Oct. 4, 2033 | 286,670 | Acquired |
| Sept. 29, 2023 | HUM | Restricted Stock Units [F3] | Humana Common (181) | — | — | 181 | Acquired |
| June 30, 2023 | HUM | Restricted Stock Units [F3] | Humana Common (215) | — | — | 215 | Acquired |
| March 31, 2023 | HUM | Restricted Stock Units [F3] | Humana Common (194) | — | — | 194 | Acquired |
| March 29, 2023 | OTLK | Stock Option (Right to Buy) | Common Stock (41,065) | $1.05 | March 29, 2033 | 41,065 | Acquired |
| Jan. 3, 2023 | HUM | Restricted Stock Units [F4] | Humana Common (380) | — | — | 380 | Acquired |
| Dec. 31, 2022 | HUM | Restricted Stock Units [F3] | Humana Common (185) | — | — | 185 | Acquired |
| Dec. 31, 2022 | HUM | Restricted Stock Units [F2] | Humana Common (205) | — | — | 205 | Acquired |
| Oct. 5, 2022 | OTLK | Stock Option (Right to Buy) | Common Stock (57,598) | $1.25 | Oct. 5, 2032 | 57,598 | Acquired |
| Sept. 30, 2022 | HUM | Restricted Stock Units [F3] | Humana Common (174) | — | — | 191 | Acquired |
| June 30, 2022 | HUM | Restricted Stock Units [F3] | Humana Common (191) | — | — | 191 | Acquired |
| March 31, 2022 | HUM | Restricted Stock Units [F3] | Humana Common (209) | — | — | 209 | Acquired |
| March 23, 2022 | OTLK | Stock Option (Right to Buy) | Common Stock (21,878) | $1.92 | March 23, 2032 | 21,878 | Acquired |
| Jan. 3, 2022 | HUM | Restricted Stock Units [F4] | Humana Common (412) | — | — | 412 | Acquired |
| Dec. 31, 2021 | HUM | Restricted Stock Units [F3] | Humana Common (185) | — | — | 185 | Acquired |
| Dec. 31, 2021 | HUM | Restricted Stock Units [F2] | Humana Common (212) | — | — | 212 | Acquired |
| Oct. 5, 2021 | OTLK | Stock Option (Right to Buy) | Common Stock (34,425) | $2.12 | Oct. 5, 2031 | 34,425 | Acquired |
| Sept. 30, 2021 | HUM | Restricted Stock Units [F3] | Humana Common (209) | — | — | 209 | Acquired |
| June 30, 2021 | HUM | Restricted Stock Units [F3] | Humana Common (194) | — | — | 194 | Acquired |
| March 31, 2021 | HUM | Restricted Stock Units [F3] | Humana Common (199) | — | — | 199 | Acquired |
| March 24, 2021 | OTLK | Stock Option (Right to Buy) | Common Stock (20,873) | $2.27 | March 24, 2031 | 20,873 | Acquired |
| Jan. 4, 2021 | HUM | Restricted Stock Units [F4] | Humana Common (403) | — | — | 403 | Acquired |
| Dec. 31, 2020 | HUM | Restricted Stock Units [F3] | Humana Common (218) | — | — | 218 | Acquired |
| Dec. 31, 2020 | HUM | Restricted Stock Units [F2] | Humana Common (227) | — | — | 227 | Acquired |
| Oct. 5, 2020 | OTLK | Stock Option (Right to Buy) | Common Stock (116,708) | $0.71 | Oct. 5, 2030 | 116,708 | Acquired |
| Oct. 1, 2020 | OTLK | Stock Option (Right to Buy) | Common Stock (217,602) | $0.71 | Oct. 1, 2030 | 217,602 | Acquired |
| Sept. 30, 2020 | HUM | Restricted Stock Units [F3] | Humana Common (207) | — | — | 207 | Acquired |
| July 17, 2020 | OTLK | Stock Option (Right to Buy) | Common Stock (210,000) | $1.58 | July 17, 2030 | 210,000 | Acquired |
| June 30, 2020 | HUM | Restricted Stock Units [F3] | Humana Common (235) | — | — | 235 | Acquired |
| March 31, 2020 | HUM | Restricted Stock Units [F3] | Humana Common (239) | — | — | 239 | Acquired |
| March 19, 2020 | OTLK | Stock Option (Right to Buy) | Common Stock (15,000) | $0.54 | March 19, 2030 | 15,000 | Acquired |
| Jan. 2, 2020 | HUM | Restricted Stock Units [F4] | Humana Common (453) | — | — | 453 | Acquired |
| Dec. 31, 2019 | HUM | Restricted Stock Units [F3] | Humana Common (239) | — | — | 239 | Acquired |
| Dec. 31, 2019 | HUM | Restricted Stock Units [F2] | Humana Common (196) | — | — | 196 | Acquired |
| Oct. 3, 2019 | OTLK | Stock Option (Right to Buy) | Common Stock (60,893) | $1.40 | Oct. 3, 2029 | 60,893 | Acquired |
| Oct. 3, 2019 | OTLK | Stock Option (Right to Buy) | Common Stock (15,000) | $1.40 | Oct. 3, 2029 | 15,000 | Acquired |
| Sept. 30, 2019 | HUM | Stock Unit [F3] | Humana Common (331) | — | — | 331 | Acquired |
| June 28, 2019 | HUM | Stock Unit [F3] | Humana Common (328) | — | — | 328 | Acquired |
| March 29, 2019 | HUM | Stock Unit [F3] | Humana Common (329) | — | — | 329 | Acquired |
| Jan. 2, 2019 | HUM | Restricted Stock Units [F4] | Humana Common (588) | — | — | 588 | Acquired |
| Dec. 31, 2018 | HUM | Stock Unit [F3] | Humana Common (284) | — | — | 284 | Acquired |
| Dec. 31, 2018 | HUM | Stock Unit [F2] | Humana Common (182) | — | — | 182 | Acquired |
| Nov. 9, 2018 | OTLK | Stock Option (Right to Buy) | Common Stock (203,851) | $0.89 | Nov. 9, 2028 | 203,851 | Acquired |
| Sept. 28, 2018 | HUM | Stock Unit [F3] | Humana Common (254) | — | — | 254 | Acquired |
| Sept. 21, 2018 | OTLK | Stock Option (Right to Buy) | Common Stock (15,000) | $0.92 | Sept. 21, 2028 | 15,000 | Acquired |
| June 29, 2018 | HUM | Stock Unit [F3] | Humana Common (280) | — | — | 280 | Acquired |
| March 29, 2018 | HUM | Stock Unit [F3] | Humana Common (311) | — | — | 311 | Acquired |
| Jan. 2, 2018 | HUM | Restricted Stock Units [F4] | Humana Common (658) | — | — | 658 | Acquired |
| Dec. 31, 2017 | HUM | Stock Unit [F3] | Humana Common (346) | — | — | 346 | Acquired |
| Dec. 31, 2017 | HUM | Stock Unit [F2] | Humana Common (173) | — | — | 173 | Acquired |
| Oct. 26, 2017 | OTLK | Stock Option (Right to Buy) | Common Stock (15,000) | $1.32 | Oct. 26, 2027 | 15,000 | Acquired |
| Sept. 29, 2017 | HUM | Stock Unit [F3] | Humana Common (355) | — | — | 355 | Acquired |
| June 30, 2017 | HUM | Stock Unit [F3] | Humana Common (318) | — | — | 318 | Acquired |
| March 31, 2017 | HUM | Stock Unit [F3] | Humana Common (371) | — | — | 371 | Acquired |
| Jan. 23, 2017 | OTLK | Warrant (Right to Buy) | Common Stock (12,036) | $0.01 | Nov. 8, 2019 | 12,036 | Disposed |
| Jan. 3, 2017 | HUM | Restricted Stock Units | Humana Common (761) | — | — | 761 | Acquired |
| Dec. 31, 2016 | HUM | Stock Unit [F3] | Humana Common (376) | — | — | 376 | Acquired |
| Dec. 31, 2016 | HUM | Stock Unit [F2] | Humana Common (144) | — | — | 144 | Acquired |
| Nov. 28, 2016 | OTLK | Warrant (Right to Buy) | Common Stock | $0.01 | Nov. 8, 2019 | 12,036 | Acquired |
| Sept. 30, 2016 | HUM | Stock Unit [F3] | Humana Common (432) | — | — | 432 | Acquired |
| June 30, 2016 | HUM | Stock Unit [F3] | Humana Common (422) | — | — | 422 | Acquired |
| March 31, 2016 | HUM | Stock Unit [F3] | Humana Common (435) | — | — | 435 | Acquired |
| Jan. 4, 2016 | HUM | Restricted Stock Units | Humana Common (870) | — | — | 870 | Acquired |
| Dec. 31, 2015 | HUM | Stock Unit [F3] | Humana Common (422) | — | — | 422 | Acquired |
| Dec. 31, 2015 | HUM | Stock Unit [F2] | Humana Common (132) | — | — | 132 | Acquired |
| Sept. 30, 2015 | HUM | Stock Unit [F3] | Humana Common (404) | — | — | 404 | Acquired |
| Sept. 10, 2015 | HUM | Stock Unit [F3] | Humana Common (327) | — | — | 327 | Acquired |
| June 30, 2015 | HUM | Stock Unit [F3] | Humana Common (384) | — | — | 384 | Acquired |
| March 31, 2015 | HUM | Stock Unit [F3] | Humana Common (427) | — | — | 427 | Acquired |
| Jan. 2, 2015 | HUM | Restricted Stock Units | Humana Common (1,077) | — | — | 1,077 | Acquired |
| Dec. 31, 2014 | HUM | Stock Unit [F3] | Humana Common (532) | — | — | 532 | Acquired |
| Dec. 31, 2014 | HUM | Stock Unit [F2] | Humana Common (143) | — | — | 143 | Acquired |
| Sept. 30, 2014 | HUM | Stock Unit [F3] | Humana Common (568) | — | — | 568 | Acquired |
| June 30, 2014 | HUM | Stock Unit [F3] | Humana Common (518) | — | — | 518 | Acquired |
| March 31, 2014 | HUM | Stock Unit [F3] | Humana Common (577) | — | — | 577 | Acquired |
| Jan. 2, 2014 | HUM | Restricted Stock Units | Humana Common (1,358) | — | — | 1,358 | Acquired |
| Dec. 31, 2013 | HUM | Restricted Stock Units | Humana Common (2,026) | — | — | 2,026 | Disposed |
| Jan. 2, 2013 | HUM | Restricted Stock Units | Humana Common (2,026) | — | — | 2,026 | Acquired |
| Oct. 26, 2012 | HUM | Stock Unit [F2] | Humana Common (51) | — | — | 51 | Acquired |
Showing latest 100 of 117 transactions
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 12, 2016 | OTLK | Restricted Stock Units [F1] | 7,246 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
COR
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2007 | $676,539 | — | — | — | $809,336 | $168,321 | $103,988 | $2,816,849 |
| 2006 | $647,116 | — | — | — | $869,440 | $0 | $105,230 | $2,220,789 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.